Abstract:Naturally occurring echinocandin B and FR901379 are potent antifungal lipopeptides featuring a cyclic hexapeptide nucleus and a fatty acid side chain. They are the parent compounds of echinocandin drugs for the treatment of severe fungal infections caused by the Candida and Aspergilla species. To minimize hemolytic toxicity, the native fatty acid side chains in these drug molecules are replaced with designer acyl side chains. The deacylation of the N-acyl side chain is, therefore, a crucial step for the development and manufacturing of echinocandin-type antibiotics. Echinocandin E (ECE) is a novel echinocandin congener with enhanced stability generated via the engineering of the biosynthetic machinery of echinocandin B (ECB). In the present study, we report the discovery of the first echinocandin E acylase (ECEA) using the enzyme similarity tool (EST) for enzymatic function mining across protein families. ECEA is derived from Streptomyces sp. SY1965 isolated from a sediment collected from the Mariana Trench. It was cloned and heterologously expressed in S. lividans TK24. The resultant TKecea66 strain showed efficient cleavage activity of the acyl side chain of ECE, showing promising applications in the development of novel echinocandin-type therapeutics. Our results also provide a showcase for harnessing the essentially untapped biodiversity from the hadal ecosystems for the discovery of functional molecules.

Two new echinocystic acid derivatives catalyzed by filamentous fungus Gliocladium roseum CGMCC 3.3657

Microbe-mediate transformation of echinocystic acid by whole cells of filamentous fungus Cunninghamella blakesleana CGMCC 3.910

Cell-Free Production of Pentacyclic Triterpenoid Compound Betulinic Acid from Betulin by the Engineered Saccharomyces cerevisiae.

Unnatural Tetradeoxy Echinocandins Produced by Gene Cluster Design and Heterologous Expression.

Two New Oxidation Products Obtained from the Biotransformation of Asiatic Acid by the Fungusfusarium Avenaceumas 3.4594

Two New Oxidation Products Obtained from the Biotransformation of Asiatic Acid by the Fungus Fusarium Avenaceum As 3.4594

A Hadal Streptomyces-Derived Echinocandin Acylase Discovered through the Prioritization of Protein Families

Selective Oxidation-Reduction and Esterification of Asiatic Acid by Pestalotiopsis Microspora and Anti-Hcv Activity

Application of acylases in the production of echinocandin antifungals

Two new compounds from biotransformation of glycyrrhetinic acid

Efficient production of icariin and baohuoside I from Epimedium Folium flavonoids by fungal α-l-rhamnosidase hydrolysing regioselectively the terminal rhamnose of epimedin C

Microbial transformation of acetyl-11-keto-boswellic acid by Cunninghamella elegans

Microbial Transformation of Asiatic Acid Byalternaria Longipes

Fusaric acid detoxification: a strategy of Gliocladium roseum involved in its antagonism against Fusarium verticillioides

An unexpected role of EasDaf: catalyzing the conversion of chanoclavine aldehyde to chanoclavine acid

Biotransformation of betulinic acid by Circinella muscae and Cunninghamella echinulata to discover anti-inflammatory derivatives

Biotransformation of pseudolaric acid B by Chaetomium globosum

Elucidation of the Pharmacophore of Echinocystic Acid, a New Lead for Blocking HCV Entry.

Bioactive Bioxanthracene and Cyclodepsipeptides from the Entomopathogenic Fungus Blackwellomyces roseostromatus BCC56290

Microbial Transformation of Ursolic Acid by Syncephalastrum Racemosum (cohn) Schroter AS 3.264.

Aculeatones A and B, epimeric lovastatin derivatives with a 6/6/3-tricyclic carbon skeleton from Aspergillus aculeatus and their chemical transformation